Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways

Aydemir M. N. , Aydemir H. B. , Korkmaz E. M. , Budak M. , Çekin N. , Pınarbaşı E.

Gene Reports, cilt.22, ss.101-112, 2021 (ESCI İndekslerine Giren Dergi)


Recently an outbreak that emerged in Wuhan, China in December 2019, spread to the whole world in a short time and killed >1,410,000 people. It was determined that a new type of beta coronavirus called severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) was causative agent of this outbreak and the disease caused by the virus was named as coronavirus disease 19 (COVID19). Despite the information obtained from the viral genome structure, many aspects of the virus-host interactions during infection is still unknown. In this study we aimed to  identify SARS-CoV-2 encoded microRNAs and their cellular targets. We  applied a  computational method to predict miRNAs encoded by SARS-CoV-2 along with their putative targets in  humans. Targets of predicted miRNAs were clustered into groups based on  their biological processes, molecular function, and cellular compartments using GO and PANTHER. By using KEGG pathway enrichment analysis top pathways were identified. Finally, we have constructed an integrative pathway network analysis with target genes. We identified 40 SARS-CoV-2 miRNAs and their regulated targets. Our analysis showed that targeted genes including NFKB1, NFKBIE, JAK1–2, STAT3–4, STAT5B, STAT6, SOCS1–6, IL2, IL8, IL10, IL17, TGFBR1–2, SMAD2–4, HDAC1–6 and JARID1A-C, JARID2 play important roles in NFKB, JAK/STAT and TGFB signaling pathways as well as cells’ epigenetic regulation pathways. Our results may help to understand virus-host interaction and the role of viral miRNAs during SARS-CoV-2 infection. As there is no current drug and effective treatment available for COVID19, it may also help to develop new treatment strategies.